COCRYSTAL PHARMA, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Percent
COCRYSTAL PHARMA, INC. (COCP) reported Effective Income Tax Rate Reconciliation, Tax Credit, Percent of 0.30% for the 12-month period ending 2018-12-31, per its 10-K filed 2019-04-01.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits · last filed 2019-04-01
- COCRYSTAL PHARMA, INC. effective income tax rate reconciliation, tax credit, percent for fiscal 2018 was 0.30%, a 90.63% decline from fiscal 2017.
- COCRYSTAL PHARMA, INC. effective income tax rate reconciliation, tax credit, percent for fiscal 2017 was 3.20%, a 700.00% increase from fiscal 2016.
- COCRYSTAL PHARMA, INC. effective income tax rate reconciliation, tax credit, percent for fiscal 2016 was 0.40%, a 33.33% increase from fiscal 2015.
- COCRYSTAL PHARMA, INC. effective income tax rate reconciliation, tax credit, percent for fiscal 2015 was 0.30%, a 66.67% decline from fiscal 2014.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month as first filed |
|---|---|---|
| 2018-12-31 | 0.30% 10-K · filed 2019-04-01 | |
| 2017-12-31 | 3.20% 10-K · filed 2019-04-01 | |
| 2016-12-31 | 0.40% 10-K · filed 2018-03-21 | |
| 2015-12-31 | 0.30% 10-K · filed 2018-03-21 | |
| 2014-12-31 | 0.90% 10-K · filed 2017-03-31 | 90.00% 10-K · filed 2015-03-31 |
| 2012-12-31 | 300.00% 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |